Abstract:The present study was design to examine the effect of tautomerism upon the CoMFA results. Three selected data sets involving protropic tautomerism, which are 21 p-hydroxyphenylpyruvate dioxygenase (HPPD) inhibitors, 35 inhibitors of puromycin-sensitive aminopeptidase (PSA), and 67 anxiolytic agents, were used for this purpose. Atom-by-atom alignment technique was adopted to superimpose the molecules in the data sets onto a template. The structural alignments using different tautomeric forms had no significant difference except the atoms involved in tautomerism, which ensures, to a great extent, that the differences of the CoMFA results result primarily from the tautomerism. All-orientation and all-placement search (AOS-APS) based CoMFA models, in addition to the conventional ones, were derived for each system and proved to be capable of yielding much improved statistical results. In the cases of the data sets of HPPD inhibitors and PSA inhibitors, excellent AOS-APS CoMFA models (q2>0.8 with four components for the former and q2>0.7 with seven components for the latter) were obtained, and almost no significant difference in statistical quality was observed when using different tautomeric forms to derive the models. However, it was not the case when treating the data set of anxiolytic agents. The keto tautomer, which was the active form of the PBI type inhibitors, produced measurably better results (q2=0.54 with eight components) than that the enol one (q2=0.37 with five components), indicating the importance of selecting proper tautomer in the CoMFA studies. Furthermore, there existed some substantial differences of the electrostatic field contours between the two different tautomeric forms for all of the three systems considered, whereas the differences in the steric field contour maps were limited. This implies that the resulting new potent ligands may be quite different if one utilizes the CoMFA models of different tautomeric forms for guiding further structural refinements.

Study On The Biological Activity Of 3-Aroyl-5-Substituted Thiophene Derivatives Based On The Comfa Method

3D-QSAR Studies on AChE Inhibitory Activities of 2-Phenoxy-indan-1-one Derivatives

QSAR Research of Novel Tetrandrine Derivatives Against Human Hepatocellular Carcinoma.

Study on the Three-Dimensional Quantitative Structure-Activity Relationship of Pyridazinonyl-Substituted 1,3,4-Thiadiazoles

Three-Dimensional Quantitative Structure-Activity Relationship Analyses of A Series of Butenolide Eta Antagonists

Studies on the 3D-Qsar of Novel 1-Aryl-1, 4-Dihydro-3-acylhydrazinocarbonyl-6-methyl-4-pyridazinones

Studies of 3D-quantitative structure-activity relationships on a set of nitroaromatic compounds: CoMFA, advanced CoMFA and CoMSIA.

Three-dimensional QSAR of HPPD inhibitors, PSA inhibitors, and anxiolytic agents: effect of tautomerism on the CoMFA models.

Studies on Three-Dimensional Qsar of Muscarinic Receptor Agonists

Three-dimensional quantitative structure–activity relationship study for analogues of TQXs using CoMFA and CoMSIA

CoMFA, CoMSIA and HQSAR studies of acetylcholinesterase inhibitors

3D-QSAR Study on 2,3-Dihydroimidazo[4,5]-pyridin-2-one Derivatives with a Meta Substitution Pattern As V600E BRAF Inhibitors

Molecular field analysis of two sets of non-peptide corticotropin-releasing hormone antagonists

Structure-based 3D-QSAR Studies on Thiazoles As 5-HT3 Receptor Antagonists

3D-QSAR Study for Inhibitors of Cyclin-Dependent Kinase 4

Recent Progress In Comparative Molecular Field Analysis

Studies on Three-Dimensional Quantitative Structure-Activity Relationships of Nonsteroidal Progesterone Receptor Agonists 5-Benzylidene-1,2-dihydro-5h-chromeno [ 3,4-F ] Quinolines

Three-Dimensional Quantitative Structure−Activity Relationship Analysis of the New Potent Sulfonylureas Using Comparative Molecular Similarity Indices Analysis

Improved 3D-QSAR Analyzes for the Predictive Toxicology of Polybrominated Diphenyl Ethers with CoMFA/CoMSIA and DFT.

Comparative molecular field analysis of fenoterol derivatives: A platform towards highly selective and effective β2-adrenergic receptor agonists

Comparative Molecular Field Analysis of γ-Hydroxy Butenolide Endothelin Antagonists